Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 19, 2008

Premium
Joseph Donahue has joined Thomson Reuters’ Scientific Division as VP of commercial operations. He will be responsible for global sales for the pharmaceutical and chemistry markets.
 
Donahue was most recently senior vice president of sales at InforSense. Prior to joining InforSense in 2005, he was co-CEO of Lion Bioscience, vice president of global life sciences and chemicals markets for Spotfire, and vice president of North American sales at MDL Information Systems.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.